Thrombocytosis as a useful prognostic indicator in patients with lung cancer

Respiration

Volumn 71, Issue 2, 2004, Pages 170-173

  Aoe, Keisuke ^a,b   Hiraki, Akio ^a,b   Ueoka, Hiroshi ^a   Kiura, Katsuyuki ^a   Tabata, Masahiro ^a   Tanaka, Motoyuki ^a   Tanimoto, Mitsune ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b NATIONAL SANYO HOSPITAL   (Japan)

Author keywords

Lung cancer; Multivariate analysis of prognostic factors; Platelet count; Poor prognosis; Thrombocytosis

Indexed keywords

LACTATE DEHYDROGENASE;

ADULT; AGE; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE MARKER; FEMALE; GENDER; HISTOPATHOLOGY; HUMAN; LACTATE DEHYDROGENASE BLOOD LEVEL; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MEDICAL RECORD; MULTIVARIATE ANALYSIS; PATHOLOGY; PERFORMANCE; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; STATISTICAL MODEL; SURVIVAL TIME; THROMBOCYTOSIS;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; FEMALE; HUMANS; JAPAN; LUNG NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; THROMBOCYTOSIS;

EID: 1942467217     PISSN: 00257931     EISSN: None     Source Type: Journal    
DOI: 10.1159/000076679     Document Type: Article

References (23)

1. Milus AJ, Schafer AJ: Thrombocytosis and thrombocythemia. Hematol Oncol Clin North Am 1990;4:157-158.
2. Costatini V, Zacharaski L, Moritz T, Edwards R: The platelet count in carcinoma of the lung and colon. Thromb Haemost 1990:64:501-505.
3. Silvis SE, Turkbas N, Doscherrholmen A: Thrombocytosis in patients with lung cancer. JAMA 1979;211:1852-1853.
4. Diehl WL, Mandelbaum I: The significance of thrombocytosis in patients with carcinoma of the lung. Surg Gynecol Obstet 1983;156:187-188.
5. Gislason T, Nou E: Sedimentation rate, leucocytes, platelet count and haemoglobin in bronchial carcinoma: An epidemiological study. Eur J Respir Dis 1985;66:141-146.
6. Engan T, Hannisdal E: Blood analysis as prognostic factors in primary lung cancer. Acta Oncol 1990;29:151-154.
7. Pedorsen LM, Milman N: Prognostic significance of thrombocytosis in patients with primary lung cancer. Eur Respir J 1996;9:1826-1830.
8. Symbas NP, Townsend MF, El GR, Keane TE, Graham SD, Petros JA: Poor prognosis associated with thrombocytosis in patients with renal cell carcinoma. BUJ Int 2000;86:203-207.
9. Hernandez E, Lavine M, Dunton CJ, Gracely E, Parker J: Poor prognosis associated with thrombocytosis in patients with cervical cancer. Cancer 1992;69:2975-2977.
10. Rodriguez GC, Clarke PD, Soper JT, Berchuck A, Synan I, Dodge RK: The negative prognostic implications of thrombocytosis in women with stage IB cervical cancer. Obstet Gynecol 1994;83:445-448.
11. Lopes A, Daras V, Cross PA, Robertson G, Beynon G, Monaghan JM: Thrombocytosis as a prognostic factor in women with cervical cancer. Cancer 1994;74:90-92.
12. Chalas E, Welshinger M, Engellener W, Chumas J, Barbrieri R, Mann WJ: The clinical significance of thrombocytosis in women presenting with a pelvic mass. Am J Obstet Gynecol 1992;166:974-977.
13. Ziemet AG, Marth C, Muller-Holzner E, Daxenbichler G, Dapunt O: Significance of thrombocytosis in patients with epithelial ovarian cancer. Am J Obstet Gynecol 1994:170:549-554.
14. Ikeda M, Furukawa H, Imamura H, Shimizu J, Ishida H, Masutani S, Tatsumu M, Satomi T: Poor prognosis associated with thrombocytosis in patients with gastric cancer. Ann Surg Oncol 2002;9:287-291.
15. Suzuki A, Takahashi T, Nakamura K, Tsuyuoka R, Okuno Y, Enomoto T, Fukumoto M, Imaru H: Thrombocytosis in patients with tumors producing colony-stimulating factor. Blood 1993;80:2052-2059.
16. Tefferi A, Ho TC, Ahmann GJ, Katzmann JA, Greipp PR: Plasma interleukin-6 and C-reactive protein levels in reactive versus clonal thrombocytosis. Am J Med 1994;97:374-378.
17. Alexandrakis MG, Passam FH, Perisinakis K, Ganotakis E, Margantinis G, Kyriakou DS, Bouros D: Serum proinflammatory cytokines and its relationship to clinical parameters in lung cancer patients with reactive thrombocytosis. Respir Med 2002;96:553-558.
18. Lidor YJ, Xu FJ, Martinez-Maza O, Olt GJ, Marks JR, Berchuck A, Ramakrishnan S, Berek JS, Bast RC Jr: Constitutive production of macrophage colony-stimulating factor and interleukin-6 by human ovarian surface epithelial cells. Exp Cell Res 1993;207:332-339.
19. Gucer F, Moser F, Tamussino K, Reich O, Haas J, Arikan G, Petru E, Winter R: Thrombocytosis as a prognostic factor in endometrial carcinoma. Gynecol Oncol 1998;70:210-214.
20. Scholz H, Petru E, Gucer F, Haas J, Tamussino K, Winter R: Preoperative thrombocytosis is an independent prognostic factor in stage III and IV endometrial cancer. Anticancer Res 2000;20:3983-3986.
21. Honn K, Tang DG, Crissman JD: Platelet and cancer metastasis: A causal relationship? Cancer Metast Rev 1992;11:325-351.
22. Karpatkin S, Pearlstein E: Role of platelets in tumor cell metastasis. Ann Intern Med 1981;95:636-641.
23. Nieswandt B, Hafner M, Echtenacher B, Mannel DN: Lysis of tumor cells by natural killer cells in mice is impeded by platelets. Cancer Res 1999;59:1295-1300.